PPRI Report (2008)

The PPRI Report provides a comparative analysis and insight in pharmaceutical pricing and reimbursement systems in 27 European countries.

Pharmaceutical prices as well as strategies for pharmaceutical pricing and reimbursement differ between the EU Member States. Within the scope of the EU project "Pharmaceutical Pricing and Reimbursement Information" (PPRI) GÖG/ÖBIG and WHO Europe established for the first time a comprehensive network. More than 50 institutions – competent authorities and other relevant institutions in the phar-maceutical sector – from EU Member States and beyond are involved of this network. The participating country representatives produced PPRI Pharma Profiles with country specific information which allowed for both a comparative analysis of key characteristics of pharma-ceutical systems and experience exchange with regard to country specific measures. Thus, this project has contributed to an improved transparency on pharmaceuticals in the EU from a public health perspective. 

 http://ppri.oebig.at

Key sections of the PPRI Report are the comparative analysis of 27 European countries and a Lessons learned chapter, including conclusions from a public health perspective.

Annex I offers 21 country reports of national pharmaceutical systems (PPRI Pharma Profiles), whereas Annex II provides further PPRI tools and reports (Needs Assessment Report, Set of Core PPRI Indicators).

PPRI Report ; Deliverables produced under the framework of the PPRI project, including the PPRI Pharma Profiles, are accessible through the PPRI website.

Download PPRI Report

Price: Euro 50,– for hard copy; including transport charge, excluding bank charges